KLK3 and prostate cancer: It has long been known that high-grade prostate cancers can lose PSA expression [9,10] and more detailed studies using the tissue microarray technology have confirmed that the expression of the PSA in the tissue can be used both as a diagnostic and prognostic parameter for prostate cancer [11].